Paper40775615
Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
Alnees M and 13 others. BMC Gastroenterol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Papers, record 40775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40775615
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Predictive factors for metabolic syndrome in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metabolic Syndrome | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Fatty Liver | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Cross-Sectional Studies | |
| Retrospective Studies | |
| Waist Circumference | |
| Triglycerides | |
| Risk Factors | |
| Blood Pressure | |
| Cholesterol, HDL | |
| Aged | |
| Adult |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31063854 | Risk factors in metabolic syndrome predict the progression of diabetic nephropathy in patients with type 2 diabetes. | Diabetes Res Clin Pract | 2019 | https://conductscience.org/library/papers/31063854 | PubMed |
| 2 | 32226553 | Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. | Theranostics | 2020 | https://conductscience.org/library/papers/32226553 | PubMed |
| 3 | 38100294 | Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings. | Hepatology | 2024 | https://conductscience.org/library/papers/38100294 | PubMed |
| 4 | 27062661 | EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. | J Hepatol | 2016 | https://conductscience.org/library/papers/27062661 | PubMed |
| 5 | 38268305 | Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study. | Endocrinol Diabetes Metab | 2024 | https://conductscience.org/library/papers/38268305 | PubMed |
| 6 | 32775749 | Population-derived cut-off for HbA1c could enhance the identification of metabolic syndrome among non-diabetic population. | Heliyon | 2020 | https://conductscience.org/library/papers/32775749 | PubMed |
| 7 | 35227957 | The impact of metabolic health on non-alcoholic fatty liver disease (NAFLD). A single center experience. | Clin Res Hepatol Gastroenterol | 2022 | https://conductscience.org/library/papers/35227957 | PubMed |
| 8 | 37700494 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review. | J Obes Metab Syndr | 2023 | https://conductscience.org/library/papers/37700494 | PubMed |
| 9 | 36677012 | Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs. | Metabolites | 2023 | https://conductscience.org/library/papers/36677012 | PubMed |
| 10 | 35283365 | Hepatic Fibrosis and Steatosis in Metabolic Syndrome. | J Obes Metab Syndr | 2022 | https://conductscience.org/library/papers/35283365 | PubMed |
| 11 | 37213404 | Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications. | World J Gastroenterol | 2023 | https://conductscience.org/library/papers/37213404 | PubMed |
| 12 | 37830733 | Interactions between Metabolic Syndrome, MASLD, and Arterial Stiffening: A Single-Center Cross-Sectional Study. | Healthcare (Basel) | 2023 | https://conductscience.org/library/papers/37830733 | PubMed |
| 13 | 36568079 | Long-term trajectories of BMI and cumulative incident metabolic syndrome: A cohort study. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36568079 | PubMed |
| 14 | 32696080 | NAFLD and cardiovascular diseases: a clinical review. | Clin Res Cardiol | 2021 | https://conductscience.org/library/papers/32696080 | PubMed |
| 15 | 38927836 | Precision Non-Alcoholic Fatty Liver Disease (NAFLD) Diagnosis: Leveraging Ensemble Machine Learning and Gender Insights for Cost-Effective Detection. | Bioengineering (Basel) | 2024 | https://conductscience.org/library/papers/38927836 | PubMed |
| 16 | 39033292 | Sustained metabolic dysregulation and the emergence of diabetes: associations between HbA1c and metabolic syndrome components in Tunisian diabetic and nondiabetic groups. | J Physiol Anthropol | 2024 | https://conductscience.org/library/papers/39033292 | PubMed |
| 17 | 31686762 | Ultrasound-based techniques for the diagnosis of liver steatosis. | World J Gastroenterol | 2019 | https://conductscience.org/library/papers/31686762 | PubMed |
| 18 | 38498331 | Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes. | Diabetes Care | 2024 | https://conductscience.org/library/papers/38498331 | PubMed |
| 19 | 38202285 | What Is New in Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals: From Bench to Bedside. | J Clin Med | 2024 | https://conductscience.org/library/papers/38202285 | PubMed |
| 20 | 30907828 | Does Weight Status Impact Metabolic Health in Adolescents When Controlling for Physical Fitness? | Pediatr Phys Ther | 2019 | https://conductscience.org/library/papers/30907828 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978133 | Circulating Estradiol as an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease and Fibrosis Risk in Women: Evidence From a Multicenter Health-Checkup Cohort. | J Korean Med Sci | 2026 | https://conductscience.org/library/papers/42978133 | PubMed |
| 42862333 | Targeting ceramides in metabolic syndrome: recent advances and therapeutic opportunities. | Acta Diabetol | 2026 | https://conductscience.org/library/papers/42862333 | PubMed |
| 41612500 | Multi-strain synbiotic and lifestyle modifications on patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a randomized double-blinded placebo-controlled trial. | Eur J Med Res | 2026 | https://conductscience.org/library/papers/41612500 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40775615
GET https://conductscience.org/api/papers/v1/40775615/references?page=2